Atezolizumab (anti-PD-L1)
Product Specifications
CAS Number
1380723-44-3
Synonyms
MPDL3280A
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1. MW : 145 KD.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680096-100 1x 100 µL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882250-100 1x 100 µL
Squamous Cell Carcinoma Antigen 1 (CPTC-SERPINB3-2), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880750-100 1x 100 µL
CD8 (C8/468 + C8/144B), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470264-100 1x 100 µL
Human Kappa Light Chain (KLC264), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details